Evidence map›Paper›PMID 41543547›Full record

ArticleEuropean journal of nuclear medicine and molecular imaging2026

Development and external validation of a FDG PET-based radiomics model predicting occult lymph node metastasis in non-small cell lung cancer patients.

Vincent Bourbonne, P Lovinfosse, M Geier, R Le Pennec, R Abgral, K Pluchon, J N Choplain, B Duysinx, F Lallemand, Arnaud Uguen and 5 more

Abstract readValidation Study
PubMed Full text at PMC Publisher
In one paragraph

Article in European journal of nuclear medicine and molecular imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Vincent BourbonneUniversity of Western Brittany, INSERM, UMR 1101, LaTIM, Brest, France. vincent.bourbonne@chu-brest.fr.ORCID 0000-0002-2631-0029
P LovinfosseDivision of Nuclear Medicine and Oncological Imaging, University Hospital of Liège, Liège, Belgium.
M GeierUniversity of Western Brittany, INSERM, UMR 1304, GETBO, Brest, France.
R Le PennecUniversity of Western Brittany, INSERM, UMR 1304, GETBO, Brest, France.
R AbgralUniversity of Western Brittany, INSERM, UMR 1304, GETBO, Brest, France.
K PluchonThoracic Surgery Department, University Hospital of Brest, Brest, France.
J N ChoplainThoracic Surgery Department, University Hospital of Brest, Brest, France.
B DuysinxPneumology Department, University Hospital of Liège, Liège, Belgium.
F LallemandRadiation Oncology Department, University Hospital of Liège, Liège, Belgium.
Arnaud UguenPathology Department, University Hospital of Brest, Brest, France.
R HustinxDivision of Nuclear Medicine and Oncological Imaging, University Hospital of Liège, Liège, Belgium.
R MagwenziUniversity of Western Brittany, INSERM, UMR 1101, LaTIM, Brest, France.
M HattUniversity of Western Brittany, INSERM, UMR 1101, LaTIM, Brest, France.
O PradierUniversity of Western Brittany, INSERM, UMR 1101, LaTIM, Brest, France.
F LuciaUniversity of Western Brittany, INSERM, UMR 1101, LaTIM, Brest, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PURPOSE/OBJECTIVE(S): Accurate detection of occult lymph node metastasis (OLNM) in patients with localized non-small cell lung cancer (NSCLC) remains a clinical challenge. This study aimed to develop and validate a radiomics-based predictive model for OLNM. MATERIALS/

methodsA radiomics model (Model

resultsIn the training cohort, the Model

conclusionThis study presents a radiomics-based predictive model for OLNM in localized NSCLC, validated across several retrospective independent cohorts. Subject to a prospective evaluation, the model could be used to refine clinical decision-making.

Indexed as

Carcinoma, Non-Small-Cell LungFluorodeoxyglucose F18Lung NeoplasmsPositron-Emission TomographyRadiomicsAgedAged, 80 and overFemaleHumansLymphatic MetastasisMaleMiddle AgedRadiopharmaceuticalsRetrospective StudiesFluorodeoxyglucose F18RadiopharmaceuticalsOccult lymph node metastasisPET-CTRadiomicsStereotactic radiotherapySurgery

Identifiers

PMID41543547
PMCPMC13121205

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.